Critical role of TLR4 in uncovering the increased rewarding effects of cocaine and ethanol induced by social defeat in male mice


Por: S. MONTAGUD-ROMERO, M. REGUILON, M. PASCUAL, M. BLANCO-GANDIA, C. GUERRI, J. MINARRO and M. RODRIGUEZ-ARIAS

Publicada: 1 ene 2021
Resumen:
Background: Substance use disorders and social stress are currently associated with changes in the immune system response by which they induce a proinflammator y state in neurons and glial cells that eventually modulates the reward system. Aims: The aim of the present work was to assess the role of the immune TLR4 (Toll-like receptors 4) and its signaling response in the increased contextual reinforcing effects of cocaine and reinforcing effects of ethanol (EtOH) induced by social defeat (SD) stress. Methods: Adult male C57BL/6 J wild-type (WT) mice and mice deficient in TLR4 (TLR4-KO) were assigned to experimental groups according to stress condition (exploration or SD). Three weeks after the last SD, conditioned place preference (CPP) was induced by a subthreshol d cocaine dose (1 mg/kg), while another set underwent EtOH 6% operant self-administration (SA). Several inflammator y molecules were analyzed in the hippocampus and the striatum. Results: SD induced higher vulnerability to the conditioned rewarding effects of cocaine only in defeated WT mice. Similarly, defeated WT mice exhibited higher 6% EtOH consumption, an effect that was not observed in the defeated TLR4-KO group. However, the motivation to obtain the drug was observed in both genotypes of defeated animals. Notably, a significant upregulation of the protein proinflammator y markers NFkBp-p65, IL-1 beta, IL-17 A and COX-2 were observed only in the defeated WT mice, but not in their defeated TLR4-KO counterparts. Conclusions: These results suggest that TLR4 receptors mediate the neuroinflammator y response underlying the increase in the rewarding effects of cocaine and EtOH induced by social stress.

Filiaciones:
S. MONTAGUD-ROMERO:
 Univ Zaragoza, Dept Psychol & Sociol, C Ciudad Escolar S-N, Teruel 44003, Spain

M. REGUILON:
 Univ Valencia, Fac Psicol, Dept Psychobiol, Avda Blasco Ibanez 21, Valencia 46010, Spain

:
 Inst Salud Carlos III, Red Temat Invest Cooperat Salud RETICS Trastornos, MICINN, Madrid, Spain

 FEDER, Madrid, Spain

 Principe Felipe Res Ctr, Dept Mol & Cellular Pathol Alcohol, Valencia 46012, Spain

 Univ Valencia, Sch Med, Dept Physiol, Valencia, Spain

M. BLANCO-GANDIA:
 Univ Zaragoza, Dept Psychol & Sociol, C Ciudad Escolar S-N, Teruel 44003, Spain

:
 Inst Salud Carlos III, Red Temat Invest Cooperat Salud RETICS Trastornos, MICINN, Madrid, Spain

 FEDER, Madrid, Spain

 Principe Felipe Res Ctr, Dept Mol & Cellular Pathol Alcohol, Valencia 46012, Spain

J. MINARRO:
 Univ Valencia, Fac Psicol, Dept Psychobiol, Avda Blasco Ibanez 21, Valencia 46010, Spain

 Inst Salud Carlos III, Red Temat Invest Cooperat Salud RETICS Trastornos, MICINN, Madrid, Spain

 FEDER, Madrid, Spain

M. RODRIGUEZ-ARIAS:
 Univ Valencia, Fac Psicol, Dept Psychobiol, Avda Blasco Ibanez 21, Valencia 46010, Spain

 Inst Salud Carlos III, Red Temat Invest Cooperat Salud RETICS Trastornos, MICINN, Madrid, Spain

 FEDER, Madrid, Spain
ISSN: 00283908





NEUROPHARMACOLOGY
Editorial
PERGAMON-ELSEVIER SCIENCE LTD, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND, Reino Unido
Tipo de documento: Article
Volumen: 182 Número:
Páginas:
WOS Id: 000599923800004
ID de PubMed: 33132187

MÉTRICAS